• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Caliper closes Xenogen Biosciences small animal deal, lowers Q4 guidance

Caliper closes Xenogen Biosciences small animal deal, lowers Q4 guidance

December 14, 2009 By MassDevice staff

Caliper Life Sciences Inc. (NSDQ:CALP) closed an $11 million deal to sell Xenogen Biosciences Corp. to Taconic Farms Inc. and lowered its fourth-quarter guidance as a result.

The Hopkinton, Mass.-based lab equipment and services provider acquired XenBio subsidiary, which supplies genetically altered small animals to drug developers, when it bought Xenogen Corp. in 2006. About 90 percent of the business involves selling genetically engineered rodents called “light producing transgenic animals,” which have been modified to produce substances that fluoresce when examined using special imaging equipment, according to Caliper’s website.

Caliper makes the equipment designed to highlight these “optical reporters,” such as luciferase, and the deal includes a distribution agreement between the company and Taconic. The Hudson, N.Y.-based small research animal supplier will distribute the Caliper light-producing transgenic animals and have the non-exclusive right to “perform imaging services under Caliper’s extensive patent estate in this field,” according to a press release. Taconic will also be able to develop new LPTA lines compatible with the Ivis imaging system.

Caliper president and CEO Kevin Hrusovsky said the deal help his company consolidate and focus on one of its core businesses, optical imaging. Caliper will get about $9 million in cash up front during the fourth quarter, plus future payments from the distribution and licensing deal.

The company downgraded its sales forecast for the fourth quarter as a result of the deal, to $33 million to $35 million. Its previous guidance was for Q4 revenues of $34.5 million to $36.5 million.

Caliper narrowed its net loss by more than 37 percent during the third quarter, despite a top-line slide of nearly 6 percent, with revenues of $32.2 million during the three months ended Sept. 30 (compared with $34 million during the same period last year). Net losses for the quarter were $3.4 million, down 37.4 percent compared with $5.4 million during the third quarter of 2008.

Filed Under: Business/Financial News, Lab Instruments & Supplies, News Well

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy